About Schrodinger Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.schrodinger.com
Frequently Asked Questions
What is the 52-week range for SDGR?
The 52-week high is $32.45 and the 52-week low is $10.945.
What is the P/E ratio for SDGR?
The P/E ratio data is currently unavailable.
What is the dividend yield for SDGR?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -16.37%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -20.98%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.62.
Analyst Recommendation Trends
Wall Street analyst consensus for SDGR over the last few months:
Latest SDGR News
'HHS launches project to speed up clinical trials' - Axios
https://www.axios.com/2026/09/30/hhs-clinical-trials-redesign
Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You
A look at the stocks that are owned by Cathie Wood's Ark Invest and Donald Trump.
Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress
Beam Therapeutics (BEAM) stock analysis: BEAM-302 gene-editing upside for 2028â2029, cash runway/dilution risks, valuation vs peersâread now.
Schrödinger (SDGR) Could Be 29% Below Fair Value Despite A 38% Overvalued View
Schrödinger (SDGR) has drawn fresh attention after recent trading left the share price at US$28.85, with the stock up strongly over the past month and past 3 months. Investors are reassessing what that move reflects. For context, Schrödinger’s recent surge sits on top of a 30-day share price return of 46.45% and a 90-day share price gain of 65.90%. At the same time, the 1-year total shareholder return of 49.48% contrasts with a 5-year total shareholder loss of 46.56%, signalling powerful...
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
RXRX's strategic partnerships are expanding its drug pipeline, strengthening AI capabilities and providing non-dilutive funding through early 2028.
Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs
Schrodinger (SDGR) is trading at new 2-year highs. SDGR maintains strong technical momentum with shares up more than 50% over the past year. SDGR maintains a 100% “Buy” technical opinion from Barchart. Analyst sentiment is mixed, with price targets from $17 to $41.17 and high short interest (15.02%). Caution is...
Why DataMEDS’ Acquisition Does Not Seem to Be Very Bullish for MEDS Stock at This Point
The low purchase price of Helomics and low revenue suggest that the acquisition is not that promising for DataMEDS AI.
SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last?
SOPHiA GENETICS (SOPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, September 17, 2026--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on September 13, 2026, the company granted restricted stock units (RSUs) with respect to 2,243 shares of the company’s common stock to three newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material induc
Vicor, Arm Holdings, Micron Technology And Other Big Stocks Moving Higher On Thursday
U.S. stocks rose; Vicor jumped 13.5% on a new license, while Generac surged 19.6% on an Amazon deal. Securitize and biotech shares rallied.
Schrödinger: Company Creation Is Now The Real Drug Business
Schrödinger's net income turned positive in Q2 2026, aided by a $48.9M gain from Ajax and increased cash reserves to $418.8M. Click for an SDGR stock update.
Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?
Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Schrödinger, Inc. (SDGR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Schrödinger, Inc. (SDGR) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 1:05 PM EDTCompany ParticipantsRamy Farid - CEO,...
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
NEW YORK, September 09, 2026--Schrödinger announced the formation of Tectora, a biotech it co-founded with NEA and RA Capital, focused on immunology and inflammation therapies.
Schrödinger Announces Formation Of Tectora, New Biotechnology Company; Tectora Secures $55M Series A Investment From NEA And RA Capital Management
Schrödinger, Inc. (NASDAQ:SDGR) today announced the formation of Tectora, a new biotechnology company it co-founded with New Enterprise Associates (NEA) and RA Capital Management, focused on developing innovative
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-17 | Akinsanya Karen | -31,599 | - | - |
| 2026-09-17 | Akinsanya Karen | -21,599 | $30 | $647,970 |
| 2026-09-17 | Akinsanya Karen | -10,000 | $28 | $280,000 |
| 2026-09-17 | Akinsanya Karen | +31,599 | $4.34 | $137,140 |
| 2026-07-16 | Jain Rachit | -875 | $15.597 | $13,647 |
| 2026-06-22 | Friesner Richard | +13,313 | - | - |
| 2026-06-22 | Friesner Richard | +8,141 | - | - |
| 2026-06-22 | Kapeller-Libermann Rosana | +13,313 | - | - |
| 2026-06-22 | Kapeller-Libermann Rosana | +8,141 | - | - |
| 2026-06-22 | Thornberry Nancy | +13,313 | - | - |
| 2026-06-22 | Thornberry Nancy | +8,141 | - | - |
| 2026-06-22 | Sender Gary | +13,313 | - | - |
| 2026-06-22 | Sender Gary | +8,141 | - | - |
| 2026-06-22 | Chodakewitz Jeffrey | +13,313 | - | - |
| 2026-06-22 | Chodakewitz Jeffrey | +8,141 | - | - |
| 2026-06-22 | Lynton Michael | +13,313 | - | - |
| 2026-06-22 | Lynton Michael | +8,141 | - | - |
| 2026-06-22 | van Kralingen Bridget A | +13,313 | - | - |
| 2026-06-22 | van Kralingen Bridget A | +8,141 | - | - |
| 2026-06-22 | OBEROI ARUN | +13,313 | - | - |
| 2026-06-22 | OBEROI ARUN | +8,141 | - | - |
| 2026-06-22 | GINSBERG GARY L | +13,313 | - | - |
| 2026-06-22 | GINSBERG GARY L | +8,141 | - | - |
| 2026-04-17 | Farid Ramy | -74,527 | - | - |
| 2026-04-17 | Farid Ramy | -43,000 | - | - |
| 2026-04-17 | Farid Ramy | +74,527 | $3.07 | $228,798 |
| 2026-04-17 | Farid Ramy | -43,000 | $12.208 | $524,944 |
| 2026-04-17 | Farid Ramy | +43,000 | $3.07 | $132,010 |
| 2026-04-16 | Jain Rachit | -844 | $12.747 | $10,758 |
| 2026-04-16 | Farid Ramy | -43,000 | - | - |
| 2026-04-16 | Farid Ramy | -43,000 | $12.331 | $530,233 |
| 2026-04-16 | Farid Ramy | +43,000 | $3.07 | $132,010 |
| 2026-03-06 | Herman Jenny | -608 | $12.842 | $7,808 |
| 2026-03-05 | Jain Rachit | -1,631 | $12.896 | $21,033 |
| 2026-03-05 | Herman Jenny | -775 | $12.846 | $9,956 |
| 2026-03-05 | Tran Yvonne | -1,094 | $12.895 | $14,107 |
| 2026-03-05 | Lorton Kenneth Patrick | -1,222 | $12.898 | $15,761 |
| 2026-03-05 | Farid Ramy | -3,661 | $12.906 | $47,249 |
| 2026-03-05 | Akinsanya Karen | -1,366 | $12.903 | $17,625 |
| 2026-03-04 | Abel Robert Lorne | -1,300 | $12.81 | $16,653 |
| 2026-03-02 | Jain Rachit | +34,250 | - | - |
| 2026-03-02 | Jain Rachit | +17,130 | - | - |
| 2026-03-02 | Aklian Mannix Vartan | +34,250 | - | - |
| 2026-03-02 | Aklian Mannix Vartan | +17,130 | - | - |
| 2026-03-02 | Friesner Richard | -160,527 | - | - |
| 2026-03-02 | Friesner Richard | +160,527 | $3.07 | $492,818 |
| 2026-03-02 | Abel Robert Lorne | +34,250 | - | - |
| 2026-03-02 | Abel Robert Lorne | +20,682 | - | - |
| 2026-03-02 | Abel Robert Lorne | +17,130 | - | - |
| 2026-03-02 | Herman Jenny | +8,220 | - | - |
| 2026-03-02 | Herman Jenny | +9,590 | - | - |
| 2026-03-02 | Tran Yvonne | +34,250 | - | - |
| 2026-03-02 | Tran Yvonne | +13,788 | - | - |
| 2026-03-02 | Tran Yvonne | +17,130 | - | - |
| 2026-03-02 | Lorton Kenneth Patrick | +34,250 | - | - |
| 2026-03-02 | Lorton Kenneth Patrick | +20,682 | - | - |
| 2026-03-02 | Lorton Kenneth Patrick | +17,130 | - | - |
| 2026-03-02 | Farid Ramy | +112,500 | - | - |
| 2026-03-02 | Farid Ramy | -5,560 | $11.8977 | $66,151 |
| 2026-03-02 | Farid Ramy | +48,259 | - | - |
| 2026-03-02 | Farid Ramy | +13,604 | - | - |
| 2026-03-02 | Farid Ramy | +56,250 | - | - |
| 2026-03-02 | Akinsanya Karen | +48,500 | - | - |
| 2026-03-02 | Akinsanya Karen | -2,206 | $11.992 | $26,454 |
| 2026-03-02 | Akinsanya Karen | +27,576 | - | - |
| 2026-03-02 | Akinsanya Karen | +6,077 | - | - |
| 2026-03-02 | Akinsanya Karen | +24,250 | - | - |
| 2026-02-10 | Herman Jenny | -752 | $13.7904 | $10,370 |
| 2026-02-10 | Tran Yvonne | -776 | $13.7956 | $10,705 |
| 2026-02-10 | Lorton Kenneth Patrick | -925 | $13.7338 | $12,704 |
| 2026-02-09 | Abel Robert Lorne | -1,230 | $13.51 | $16,617 |
| 2025-10-16 | Dugan Margaret | -1,395 | $21.066 | $29,387 |